3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
11
Neoplasms
5
Depression
3
Weight Loss
2
Polycystic Ovary Syndrome
2
Parasomnias
2
Pain
2
Lung Neoplasms
2
Fatigue
2
Cachexia
2
Anxiety Disorders
2
Uveal Melanoma
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Wake Disorders
1
Sleep Disorders, Circadian Rhythm
1
Relapsed Malignant Solid Tumor
1
Radiodermatitis
1
Quality of Life
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma
1
Leukoplakia, Oral
1
Keratosis, Actinic
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Female Breast Cancer
1
Delirium
1
Cardiovascular Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer - Female
1
Interventions
Ipilimumab
17
Nivolumab
15
incomplete Freund's adjuvant
8
Cyclophosphamide
7
CTLA-4 Antigen
7
pembrolizumab
6
Ranibizumab
6
sargramostim
5
Radiosurgery
5
Blood Specimen Collection
5
tebentafusp
4
Temozolomide
4
Surveys and Questionnaires
4
Magnetic Resonance Spectroscopy
4
MART-1 Antigen
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Biopsy
4
Bevacizumab
4
fludarabine phosphate
3
fludarabine
3
aflibercept
3
Thalidomide
3
Sunitinib
3
Specimen Handling
3
MAGEA3 protein, human
3
Interleukin-2
3
130-nm albumin-bound paclitaxel
3
relatlimab
2
olaparib
2
montanide ISA 51
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uveal Melanoma
×
Melatonin
×
Clear all
NCT05502900
2025-05-15
AMUM
St. Erik Eye Hospital
Phase 3
Recruiting
100 enrolled